- Home
- AQST vs AMBI Comparison
AQST vs AMBI Comparison
Compare AQST & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- AMBI
- Stock Information
- Founded
- AQST 2004
- AMBI 1995
- Country
- AQST United States
- AMBI Brazil
- Employees
- AQST N/A
- AMBI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- AMBI Environmental Services
- Sector
- AQST Health Care
- AMBI Industrials
- Exchange
- AQST Nasdaq
- AMBI Nasdaq
- Market Cap
- AQST 272.9M
- AMBI 242.5M
- IPO Year
- AQST 2018
- AMBI N/A
- Fundamental
- Price
- AQST $3.25
- AMBI $4.45
- Analyst Decision
- AQST Strong Buy
- AMBI
- Analyst Count
- AQST 6
- AMBI 0
- Target Price
- AQST $10.67
- AMBI N/A
- AVG Volume (30 Days)
- AQST 1.6M
- AMBI 5.7K
- Earning Date
- AQST 08-05-2025
- AMBI 08-12-2014
- Dividend Yield
- AQST N/A
- AMBI N/A
- EPS Growth
- AQST N/A
- AMBI N/A
- EPS
- AQST N/A
- AMBI N/A
- Revenue
- AQST $54,228,000.00
- AMBI $532,477,487.00
- Revenue This Year
- AQST N/A
- AMBI N/A
- Revenue Next Year
- AQST $45.71
- AMBI N/A
- P/E Ratio
- AQST N/A
- AMBI N/A
- Revenue Growth
- AQST 5.29
- AMBI 27.16
- 52 Week Low
- AQST $2.12
- AMBI $3.22
- 52 Week High
- AQST $5.80
- AMBI $8.20
- Technical
- Relative Strength Index (RSI)
- AQST 54.57
- AMBI 52.59
- Support Level
- AQST $3.20
- AMBI $4.58
- Resistance Level
- AQST $3.61
- AMBI $5.40
- Average True Range (ATR)
- AQST 0.28
- AMBI 0.26
- MACD
- AQST -0.00
- AMBI 0.02
- Stochastic Oscillator
- AQST 50.44
- AMBI 57.79
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.